Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TriSalus Life Sciences, Inc. | 72,510 | reported | 15 May 2026 | tx 8+185,163 |
| Ayala Pharmaceuticals, Inc. | 0 | reported | 19 Jan 2023 | tx 14+115,640−210,640 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | PURCHASE | TriSalus Life Sciences, Inc. | 10,000 | 2.46 USD | |
| 14 May 2026 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 28,201 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 24,553 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 56,403 | 0.00 USD | deriv |
| 23 Feb 2026 | PURCHASE | TriSalus Life Sciences, Inc. | 9,756 | 4.10 USD | |
| 12 Jun 2025 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 15,000 | 0.00 USD | deriv |
| 29 Jan 2025 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 35,000 | 0.00 USD | deriv |
| 29 Jan 2025 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 6,250 | 0.00 USD | deriv |
| 19 Jan 2023 | OTHER | Ayala Pharmaceuticals, Inc. | 58,520 | — | |
| 19 Jan 2023 | OTHER | Ayala Pharmaceuticals, Inc. | 89,000 | — | deriv |
| 19 Jan 2023 | OTHER | Ayala Pharmaceuticals, Inc. | 31,950 | — | deriv |
| 19 Jan 2023 | OTHER | Ayala Pharmaceuticals, Inc. | 19,170 | — | deriv |
| 16 May 2022 | GRANT_AWARD | Ayala Pharmaceuticals, Inc. | 50,000 | 0.00 USD | |
| 03 Jan 2022 | GRANT_AWARD | Ayala Pharmaceuticals, Inc. | 31,950 | 0.00 USD | deriv |
| 24 Feb 2021 | SALE | Ayala Pharmaceuticals, Inc. | 3,000 | 17.46 USD | |
| 24 Feb 2021 | EXERCISE | Ayala Pharmaceuticals, Inc. | 3,000 | 5.16 USD | |
| 24 Feb 2021 | EXERCISE | Ayala Pharmaceuticals, Inc. | 3,000 | 0.00 USD | deriv |
| 20 Jan 2021 | SALE | Ayala Pharmaceuticals, Inc. | 3,000 | 15.03 USD | |
| 20 Jan 2021 | EXERCISE | Ayala Pharmaceuticals, Inc. | 3,000 | 5.16 USD | |
| 20 Jan 2021 | EXERCISE | Ayala Pharmaceuticals, Inc. | 3,000 | 0.00 USD | deriv |
| 04 Jan 2021 | GRANT_AWARD | Ayala Pharmaceuticals, Inc. | 8,520 | 0.00 USD | |
| 04 Jan 2021 | GRANT_AWARD | Ayala Pharmaceuticals, Inc. | 19,170 | 0.00 USD | deriv |